- What we might expect in hereditary angioedema with C1 inhibitor deficiency treatment?2017 | Second Faculty of Medicine
- Acquired angioedema with C1 inhibitor deficiency in a patient with low-grade B-lymphoma and the effect of underlying disease treatment on angioedema manifestations2017 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic Patients2021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- No Evidence for Linkage between the Hereditary Angiooedema Clinical Phenotype and the BDKR1, BDKR2, ACE or MBL2 gene2011 | Second Faculty of Medicine
- Current treatment options for hereditary angioedema2017 | Second Faculty of Medicine
- Hereditary angioedema and current possibilities of its treatment in the Czech Republic2020 | Second Faculty of Medicine
- Lanadelumab in hereditary angioedema treatment2022 | Second Faculty of Medicine
- Angiotensin-converting enzyme inhibitor-induced angioedema: epidemiology, pathogenesis and management2018 | Second Faculty of Medicine
- Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort2023 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children2019 | Publication without faculty affiliation